192 related articles for article (PubMed ID: 23615069)
21. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.
Miotto P; Piana F; Penati V; Canducci F; Migliori GB; Cirillo DM
J Clin Microbiol; 2006 Jul; 44(7):2485-91. PubMed ID: 16825369
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterisation of drug resistance in Mycobacterium tuberculosis isolates from North India.
Yadav R; Sethi S; Dhatwalia SK; Gupta D; Mewara A; Sharma M
Int J Tuberc Lung Dis; 2013 Feb; 17(2):251-7. PubMed ID: 23317963
[TBL] [Abstract][Full Text] [Related]
23. Molecular characterization of INH-resistant Mycobacterium tuberculosis isolates by PCR-RFLP and multiplex-PCR in North India.
Mathuria JP; Nath G; Samaria JK; Anupurba S
Infect Genet Evol; 2009 Dec; 9(6):1352-5. PubMed ID: 19786122
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of GenoType MTBDRplus for the detection of multi-drug-resistant Mycobacterium tuberculosis strains].
Chikamatsu K; Mizuno K; Aono A; Yamada H; Sugamoto T; Nishiyama H; Mitarai S
Kekkaku; 2011 Jul; 86(7):697-702. PubMed ID: 21922778
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the GenoType® MTBDRplus assay and identification of a rare mutation for improving MDR-TB detection.
Jin J; Zhang Y; Fan X; Diao N; Shao L; Wang F; Hu P; Wang S; Weng X; Zhang W
Int J Tuberc Lung Dis; 2012 Apr; 16(4):521-6. PubMed ID: 22325117
[TBL] [Abstract][Full Text] [Related]
26. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
Gagneux S; Long CD; Small PM; Van T; Schoolnik GK; Bohannan BJ
Science; 2006 Jun; 312(5782):1944-6. PubMed ID: 16809538
[TBL] [Abstract][Full Text] [Related]
27. Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa.
Evans J; Stead MC; Nicol MP; Segal H
J Antimicrob Chemother; 2009 Jan; 63(1):11-6. PubMed ID: 18940875
[TBL] [Abstract][Full Text] [Related]
28. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y
Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936
[TBL] [Abstract][Full Text] [Related]
29. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
[TBL] [Abstract][Full Text] [Related]
30. [Process of acquiring drug resistance: retrospective review of records of MDR TB].
Yoshiyama T; Ito K; Ogata H; Mitarai S; Hoshino H; Okumura M; Aman K; Aono A; Wada M
Kekkaku; 2004 Dec; 79(12):717-24. PubMed ID: 15782617
[TBL] [Abstract][Full Text] [Related]
31. [Cross-resistance between rifampicin and rifabutin among multi-drug resistant Mycobacterium tuberculosis strains].
Chikamatsu K; Mizuno K; Yamada H; Mitarai S
Kekkaku; 2009 Sep; 84(9):631-3. PubMed ID: 19860266
[TBL] [Abstract][Full Text] [Related]
32. Characterization of multiple and extensively drug resistant Mycobacterium tuberculosis isolates with different ofloxacin-resistance levels.
Chernyaeva E; Fedorova E; Zhemkova G; Korneev Y; Kozlov A
Tuberculosis (Edinb); 2013 May; 93(3):291-5. PubMed ID: 23491718
[TBL] [Abstract][Full Text] [Related]
33. Expression analysis of efflux pump genes among drug-susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates and reference strains.
Calgin MK; Sahin F; Turegun B; Gerceker D; Atasever M; Koksal D; Karasartova D; Kiyan M
Diagn Microbiol Infect Dis; 2013 Jul; 76(3):291-7. PubMed ID: 23561272
[TBL] [Abstract][Full Text] [Related]
34. Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.
Alcaide F; Coll P
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():34-40. PubMed ID: 21420565
[TBL] [Abstract][Full Text] [Related]
35. The use of macroarrays for the identification of MDR Mycobacterium tuberculosis.
Brown TJ; Herrera-Leon L; Anthony RM; Drobniewski FA
J Microbiol Methods; 2006 May; 65(2):294-300. PubMed ID: 16153726
[TBL] [Abstract][Full Text] [Related]
36. Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant Mycobacterium tuberculosis: A Household-Based Case-Control Study.
Salvatore PP; Becerra MC; Abel zur Wiesch P; Hinkley T; Kaur D; Sloutsky A; Cohen T
J Infect Dis; 2016 Jan; 213(1):149-55. PubMed ID: 26092854
[TBL] [Abstract][Full Text] [Related]
37. Increased in vitro fitness of multi- and extensively drug-resistant F15/LAM4/KZN strains of Mycobacterium tuberculosis.
Naidoo CC; Pillay M
Clin Microbiol Infect; 2014 Jun; 20(6):O361-9. PubMed ID: 24118525
[TBL] [Abstract][Full Text] [Related]
38. [The cluster and drug-resistant characteristics of Beijing genotype Mycobacterium tuberculosis in eastern rural China].
Ma H; Hu Y; Jiang WL; Wang WB; Xu B
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):447-50. PubMed ID: 21781518
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the GenoCard as a tool for transport and storage of samples for tuberculosis molecular drug susceptibility testing.
Miotto P; Piana F; Migliori GB; Cirillo DM
New Microbiol; 2008 Jan; 31(1):147-50. PubMed ID: 18437855
[TBL] [Abstract][Full Text] [Related]
40. M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.
Kibiki GS; Mulder B; Dolmans WM; de Beer JL; Boeree M; Sam N; van Soolingen D; Sola C; van der Zanden AG
BMC Microbiol; 2007 May; 7():51. PubMed ID: 17540031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
